celastrol has been researched along with Uveal Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Y; Jiang, W; Li, Z; Wang, R; Xie, C; Xie, S; Xie, X | 1 |
| Jiang, Y; Lazarovici, P; Li, S; Liao, R; Peng, T; Silva, M; Yan, F; Zheng, W | 1 |
| Pan, J; Zhang, B; Zhang, J | 1 |
3 other study(ies) available for celastrol and Uveal Neoplasms
| Article | Year |
|---|---|
Pristimerin attenuates cell proliferation of uveal melanoma cells by inhibiting insulin-like growth factor-1 receptor and its downstream pathways.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Humans; Melanoma; Molecular Docking Simulation; Pentacyclic Triterpenes; Phosphorylation; Receptor, IGF Type 1; Signal Transduction; Triterpenes; Uveal Neoplasms | 2019 |
Pristimerin-induced uveal melanoma cell death via inhibiting PI3K/Akt/FoxO3a signalling pathway.
Topics: Apoptosis; bcl-2-Associated X Protein; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Nucleus; Forkhead Box Protein O3; Humans; Melanoma; Neoplasm Invasiveness; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Phosphorylation; Poly(ADP-ribose) Polymerases; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Signal Transduction; Uveal Neoplasms | 2020 |
Pristimerin effectively inhibits the malignant phenotypes of uveal melanoma cells by targeting NF‑κB pathway.
Topics: Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Melanoma; Molecular Targeted Therapy; Neoplastic Stem Cells; NF-kappa B; NF-KappaB Inhibitor alpha; Pentacyclic Triterpenes; Signal Transduction; Transcription Factor RelA; Triterpenes; Tumor Necrosis Factor-alpha; Uveal Neoplasms; Vinblastine | 2017 |